These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1126 related items for PubMed ID: 19752375

  • 1. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC, Robbins RC, Schrepfer S.
    Circulation; 2009 Sep 15; 120(11 Suppl):S247-54. PubMed ID: 19752375
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function.
    Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lützow K, Lendlein A, Stamm C, Li RK, Steinhoff G.
    Stem Cells; 2007 Aug 15; 25(8):2118-27. PubMed ID: 17478584
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B, Zhou F, Zhu TB, Wang LS, Xu ZQ, Zhang FM, Cao KJ, Ma WZ.
    Gene Ther; 2006 Nov 15; 13(22):1564-8. PubMed ID: 16810195
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combining angiogenic gene and stem cell therapies for myocardial infarction.
    Pons J, Huang Y, Takagawa J, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW, Su H.
    J Gene Med; 2009 Sep 15; 11(9):743-53. PubMed ID: 19554624
    [Abstract] [Full Text] [Related]

  • 11. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
    Wang YQ, Wang M, Zhang P, Song JJ, Li YP, Hou SH, Huang CX.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2290-8. PubMed ID: 19080335
    [Abstract] [Full Text] [Related]

  • 12. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J, Xie Q, Pan G, Wang J, Wang M.
    Eur J Cardiothorac Surg; 2006 Aug 20; 30(2):353-61. PubMed ID: 16829080
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model.
    Lim SY, Kim YS, Ahn Y, Jeong MH, Hong MH, Joo SY, Nam KI, Cho JG, Kang PM, Park JC.
    Cardiovasc Res; 2006 Jun 01; 70(3):530-42. PubMed ID: 16563361
    [Abstract] [Full Text] [Related]

  • 15. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction.
    Tang YL, Zhao Q, Qin X, Shen L, Cheng L, Ge J, Phillips MI.
    Ann Thorac Surg; 2005 Jul 01; 80(1):229-36; discussion 236-7. PubMed ID: 15975372
    [Abstract] [Full Text] [Related]

  • 16. Stem cells improve right ventricular functional recovery after acute pressure overload and ischemia reperfusion injury.
    Wairiuko GM, Crisostomo PR, Wang M, Morrell ED, Meldrum KK, Lillemoe KD, Meldrum DR.
    J Surg Res; 2007 Aug 01; 141(2):241-6. PubMed ID: 17583739
    [Abstract] [Full Text] [Related]

  • 17. Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism.
    Poynter JA, Herrmann JL, Manukyan MC, Wang Y, Abarbanell AM, Weil BR, Brewster BD, Meldrum DR.
    J Am Coll Surg; 2011 Aug 01; 213(2):253-60. PubMed ID: 21546276
    [Abstract] [Full Text] [Related]

  • 18. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL, Wang Y, Abarbanell AM, Weil BR, Tan J, Meldrum DR.
    Shock; 2010 Jan 01; 33(1):24-30. PubMed ID: 19996917
    [Abstract] [Full Text] [Related]

  • 19. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY, Cho HJ, Kang HJ, Kim TS, Kim MH, Chung JH, Bae JW, Oh BH, Park YB, Kim HS.
    J Am Coll Cardiol; 2008 Mar 04; 51(9):933-43. PubMed ID: 18308163
    [Abstract] [Full Text] [Related]

  • 20. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.
    Yang J, Zhou W, Zheng W, Ma Y, Lin L, Tang T, Liu J, Yu J, Zhou X, Hu J.
    Cardiology; 2007 Mar 04; 107(1):17-29. PubMed ID: 16741354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.